NoazRX
PrivateLast Round
Series C
May 20, 2022
Est. Valuation
$297.5M
Total Funding Raised
$53.72M
Company Overview
NoazRX operates in Healthcare & Life Sciences and is based in Abbotsford. Its latest recorded funding round was a Series C round in May 2022.
NoazRX is a healthcare logistics technology company that provides pharmacy delivery support, including temperature and custody visibility, proof-of-delivery workflows, and operational services for pharmacies and health systems.
Sector
Healthcare & Life Sciences
Verticals
Logistics Software, Last-Mile Delivery, Pharma Supply Chain, Route Optimization, Compliance
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NoazRX Comparables
Compare NoazRX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RedSail Technologies | 79% | |
| Vantage Point Logistics | 79% | |
| GoodRx | 77% |
For institutional investors. Book with your work email.
NoazRX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 20, 2022 | ||||
| Series B | Jul 15, 2020 | ||||
| Debt | Jul 1, 2020 | ||||
| Series A | Oct 16, 2018 | ||||
| Seed | Dec 31, 2017 |
For institutional investors. Book with your work email.
NoazRX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Decathlon Capital Partners | Debt |
| SeedInvest | Series B, Series C, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 6, 2026
Monthly visitors grew 3602% MoM, from 59 to 2.2K.
- May 20, 2022
$23M round led by SeedInvest.
For institutional investors. Book with your work email.
NoazRX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NoazRX's valuation, stock price, and market status.
Is NoazRX a public or private company?
NoazRX is a private company.
What is the current stock price of NoazRX?
NoazRX is a private company, so its shares have no public market price. Caplight tracks NoazRX's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NoazRX worth (valuation)?
NoazRX's valuation is estimated at $297.5M based on funding round data.
Can I buy NoazRX stock?
NoazRX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NoazRX's last funding round?
NoazRX's most recent funding round was Series C on May 20, 2022.
Who are the main investors in NoazRX?
Key investors in NoazRX include Decathlon Capital Partners.
Will NoazRX IPO soon?
No public IPO plans have been announced for NoazRX.
How can I track NoazRX secondary market activity?
Caplight tracks bids, offers, and trades in NoazRX's shares on secondary markets.